Treatment with Partamol Extra, prescribe the lowest effective dose for the shortest duration possible.
It should not be used:
- For self-medication of pain for longer than 10 days in adults;
- For self-medication of marked fever (greater than 39.5oC), fever persisting longer than 3 days, or recurrent fever.
Caution is advised when use for:
- The elderly and patients with haemorrhagic disorders, hypertension, and impaired renal, hepatic, or cardiac function;
- Patients suffering from, or with a history of, bronchial asthma or allergic disease NSAIDs have been reported to precipitate bronchospasm;
- Patient with systemic lupus erythematosus (SLE) and mixed connective tissue disease disorders there may be an increased risk of aseptic meningitis.
The physicians need to warn the patients of the signs of serious skin reactions known as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) or Lyell’s syndrome, acute generalized exanthematous pustulosis (AGEP).
Physicians should assess periodically appearance of cardiovascular adverse events, even in the absence of previous cardiovascular symptoms. Patients should be warned about the symptoms of serious cardiovascular events and seek physicians immediately if these symptoms occur.
Gastrointestinal (GI) bleeding, ulceration and perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.
The use of the product may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of the product should be considered.
Partamol Extra contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Partamol Extra contains the azo colouring agent e.g., sunset yellow, which may cause allergic reactions.
Use Partamol Extra with caution in nursing women.
Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected patients should not drive or operate machinery.